Boston Scientific (NYSE:BSX) said it won FDA approval for its Precision Montage MRI-safe spinal cord stimulator for chronic pain and plans to launch the device tomorrow. The Precision Montage MRI SCS is cleared for full-body, 1.5 Tesla MRI scans, the Marlborough, Mass.-based company said. It’s designed to deliver multiple waveforms so patients can tailor their therapy as their pain […]
Pain Management
PureTech launches Alivio inflammation focused drug-delivery biz
PureTech Health said today it launched Alivio Therapeutics, a new novel tech business aiming to treat inflammatory disorders. The newly-launched company’s technology is based on hydrogel material designed to adhere to and deliver drugs to inflamed tissue based on the degree of inflammation, the Boston-based company said. The technology was jointly developed by Alivio co-founders […]
New implant set to join fight against U.S. painkiller epidemic
(Reuters) – Two companies are on the cusp of taking a new treatment for opioid addiction to the U.S. market at a time when lawmakers are seeking ways to arrest an epidemic of heroin and painkiller abuse that kills 78 Americans every day. Titan Pharmaceuticals Inc and privately owned Braeburn Pharmaceuticals have together developed a […]
St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain. The 1st patients were implanted in West Virginia and California with the Axium device, which uses dorsal root ganglion stimulation to treat moderate to severe chronic intractable pain of the lower limbs in adult patients […]
Calmare wins $15m DoD contract
Pain mitigation company Calmare Therapeutics said yesterday it won a general supply order contract from the U.S. Department of Defense for an estimated $15 million over the next 60 months. The Fairfield, Conn.-based company’s flagship product is its Calmare Pain Therapy Device, which is designed as a non-invasive and non-addictive neuropathic pain treatment modality, and has […]
OrthoCor picked up by veterinary med device firm Caerus Corp
Non-invasive medical device maker OrthoCor said yesterday it was acquired by veterinary-focused medical device firm Caerus Corp, who said the company will remain independent and focused on the orthopedic market. OrthoCor’s flagship product is its Active System, which uses pulsed electromagnetic field technology to reduce joint pain and restore physical function to patients, the company […]
NeuroMetrix jumps on next-gen Quell FDA nod, but can’t hold momentum
NeuroMetrix (NSDQ:NURO) saw shares jump as high as 37% yesterday after announcing it won FDA 510(k) clearance for an upgraded version of its Quell wearable over-the-counter chronic pain relief device, though shares haven’t held onto the inertia in trading today. The new model is designed to be controlled through a company-developed smartphone app, and has an […]
Boston Scientific touts improved back pain relief in Spectra SCS trial
Boston Scientific (NYSE:BSX) today released data from the Lumina trial of its Precision Spectra spinal cord stimulator, touting a 70% improvement in back pain relief over its previous generation Precision Plus SCS. Data from the Lumina study is being presented at the North American Neuromodulation Society’s annual meeting in Las Vegas this weekend, the company said. “As […]
NeuroMetrix shares slump after clearing 1-for-4 split
NeuroMetrix (NSDQ:NURO) said today it consummated its 1 for 4 reverse split of its common stock, trading at a split-adjusted basis yesterday. Stocks rose on Tuesday to open at $3.01, but dropped to close at $2.65. Today, shares of NURO opened at $2.70 and fell over 6% to close at $2.43, down roughly 19% from its opening price on […]
FDA OKs trial for StimRelieve’s facial pain device
StimRelieve said today that it won an investigational device exemption for a clinical trial of its neurostimulation treatment for treating refractory craniofacial neuropathic pain. Ft. Lauderdale, Fla.-based StimRelieve said its Halo CFNS device, using wirelessly-powered, nanotech neurostimulators, is 95% smaller than other implantable treatment options. The wireless device, powered by an external transmitter in the ear, is implanted […]
Nevro beats Boston Scientific’s patent challenges
Nevro Corp. (NYSE:NVRO) yesterday beat a pair of challenges to 1 of its patents by Boston Scientific (NYSE:BSX), after the U.S. Patent & Trademark office declined to institute inter partes reviews. Nevro’s Senza device, which won pre-market approval from the FDA in May, is designed to deliver up to 10,000Hz to the spinal cord, allowing it to avoid the […]